The Experience in Neurorehabilitation Setting: a Qualitative Study
Launched by IRCCS SAN CAMILLO, VENEZIA, ITALY · Feb 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "The Experience in Neurorehabilitation Setting," aims to explore and understand the experiences of patients who are hospitalized for neurological disorders like stroke, multiple sclerosis, Parkinson's disease, and those recovering from neurosurgery related to cancer. Researchers will conduct interviews with patients to gather their thoughts and feelings about their treatment and hospital stay. This study is currently recruiting participants who are staying at IRCCS San Camillo for at least 21 days and can communicate in Italian.
To be eligible, patients must be hospitalized for one of the specified conditions and be able to provide consent. Those who may not qualify include minors, individuals over 85 years old, or those with severe cognitive or psychiatric issues that would prevent them from participating in an interview. Participants can expect to share their personal experiences in a supportive environment, contributing to a better understanding of how to improve care for people in similar situations.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria:● Patients hospitalized at the IRCCS San Camillo.
- • patients in Stroke, Multiple Sclerosis, Parkinson\'s Disease and post-operative patients in Neurosurgery for oncological pathology
- • Patients who have given valid consent.
- • Patients able to understand, read and speak Italian.
- • Aphasic patients without comprehension deficits and able to communicate effectively with augmented communication media.
- • hospitalized for at least 21 days and not close to discharge, or that this occurs at least after 21 days.
- • Exclusion Criteria:● Patients unable to give valid consent.
- • Minor patients or patients over 85 years of age.
- • Patients with cognitive deficits such that they cannot effectively support the interview.
- • Patients with psychiatric pathology
- • Patients unable to understand, read and speak Italian.
- • Patients with pathologies for which they are not undergoing neurorehabilitation treatment.
About Irccs San Camillo, Venezia, Italy
IRCCS San Camillo, located in Venice, Italy, is a renowned clinical research institute dedicated to advancing medical science through innovative research and high-quality clinical trials. As a recognized Institute of Hospitalization and Care for Scientific Research (IRCCS), it specializes in various fields, including neurology, psychiatry, and rehabilitation. With a commitment to improving patient outcomes, IRCCS San Camillo collaborates with national and international research networks, fostering a multidisciplinary approach to healthcare challenges. The institute emphasizes ethical standards and patient safety, ensuring that all trials adhere to rigorous regulatory guidelines while contributing valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Venezia, , Italy
Venezia, , Italy
Venezia, , Italy
Patients applied
Trial Officials
Alberto Camuccio, doctor
Principal Investigator
IRCCS San Camillo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported